These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vaccination against nicotine: an emerging therapy for tobacco dependence. Maurer P; Bachmann MF Expert Opin Investig Drugs; 2007 Nov; 16(11):1775-83. PubMed ID: 17970637 [TBL] [Abstract][Full Text] [Related]
6. Nicotine vaccines to assist with smoking cessation: current status of research. Raupach T; Hoogsteder PH; Onno van Schayck CP Drugs; 2012 Mar; 72(4):e1-16. PubMed ID: 22356293 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612 [TBL] [Abstract][Full Text] [Related]
8. Nicotine conjugate vaccine as a novel approach to smoking cessation. Ottney AR Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; van Schayck OC Addiction; 2014 Aug; 109(8):1252-9. PubMed ID: 24894625 [TBL] [Abstract][Full Text] [Related]
10. [Smoking reduction and temporary abstinence: new approaches for smoking cessation]. Le Houezec J; Säwe U J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435 [TBL] [Abstract][Full Text] [Related]
12. [Expecting the antinicotine vaccine]. Didilescu C Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315 [TBL] [Abstract][Full Text] [Related]
13. Targeting nicotine addiction: the possibility of a therapeutic vaccine. Escobar-Chávez JJ; Domínguez-Delgado CL; Rodríguez-Cruz IM Drug Des Devel Ther; 2011; 5():211-24. PubMed ID: 21607018 [TBL] [Abstract][Full Text] [Related]
14. A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder. Hicks TA; Thomas SP; Wilson SM; Calhoun PS; Kuhn ER; Beckham JC J Dual Diagn; 2017; 13(1):15-20. PubMed ID: 27918881 [TBL] [Abstract][Full Text] [Related]
16. Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial. Tonstad S; Heggen E; Giljam H; Lagerbäck PÅ; Tønnesen P; Wikingsson LD; Lindblom N; de Villiers S; Svensson TH; Fagerström KO Nicotine Tob Res; 2013 Sep; 15(9):1492-501. PubMed ID: 23471101 [TBL] [Abstract][Full Text] [Related]
17. Vaccines against nicotine: how effective are they likely to be in preventing smoking? Vocci FJ; Chiang CN CNS Drugs; 2001; 15(7):505-14. PubMed ID: 11510621 [TBL] [Abstract][Full Text] [Related]
18. Anti-nicotine abuse vaccines in the pipeline: an update. Cerny EH; Cerny T Expert Opin Investig Drugs; 2008 May; 17(5):691-6. PubMed ID: 18447595 [TBL] [Abstract][Full Text] [Related]
19. Probing the protective effects of a conformationally constrained nicotine vaccine. Moreno AY; Azar MR; Koob GF; Janda KD Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803 [TBL] [Abstract][Full Text] [Related]
20. [Current and future medical drugs for smoking cessation]. Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]